Will Pfizer Stock Go Up Like Moderna. At $50.18, pfe stock is trading at a forward. Analysts expect that pfizer will report earnings of $7.23 per share in the current year and earnings of $5.69 per share in the next year, so the stock is trading at 9 forward p/e.
Data show that following up johnson & johnson’s vaccine with a booster of an mrna vaccine creates a stronger immune response and lessens the risk of serious side effects, the centers for disease. Furthermore, for 2022, pfizer has provided an earnings per share guidance of $6.45. At $50.18, pfe stock is trading at a forward.
Data Show That Following Up Johnson & Johnson’s Vaccine With A Booster Of An Mrna Vaccine Creates A Stronger Immune Response And Lessens The Risk Of Serious Side Effects, The Centers For Disease.
Furthermore, for 2022, pfizer has provided an earnings per share guidance of $6.45. Analysts expect that pfizer will report earnings of $7.23 per share in the current year and earnings of $5.69 per share in the next year, so the stock is trading at 9 forward p/e. At $50.18, pfe stock is trading at a forward.